Report #2833693

Overview

Sex

Female

Age

Age unknown

State

MD

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

patient received first Shingrix vaccine about 10 months ago, and they receive their second now; This non-serious case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a adult female patient who received Herpes zoster (Shingrix) (batch number X5J23, expiry date 25-JAN-2026) for prophylaxis. Previously administered products included Shingrix (first Shingrix vaccine about 10 months ago). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: patient received first Shingrix vaccine about 10 months ago, and they receive their second now). The outcome of the drug dose administration interval too long was not applicable. Additional Information: GSK Receipt Date: 18-MAR-2025 The patient received their first Shingrix vaccine about 10 months ago, and they receive their second now which led to Drug dose administration interval too long. No further details were collected.